VVUS

Recent Articles

13 Pharmaceuticals Stocks to Sell Now

The ratings of 13 Pharmaceuticals stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

14 Pharmaceuticals Stocks to Sell Now

The overall ratings of 14 Pharmaceuticals stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

12 Pharmaceuticals Stocks to Sell Now

This week, 12 Pharmaceuticals stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

Vivus, Inc.: Don’t Overthink This Bullish Move in VVUS

Surprise! Vivus stock has been one of the market's hottest names since September. Maybe we should trust the guy making it happen. More 

5 Best Stocks Under $5 This Week

Envivio, Vivus, Medovex, One Group Hospitality and VolitionRX were among a number of cheap stocks that charged significantly higher this week. More 

Vivus, Inc. (VVUS): Earnings Preview

The VIVUS earnings report coming on Monday could be a harsh reality check about the long-term prospects for Qsymia. More 

Orexigen (OREX) Stock Shoots Higher as Contrave Goes on Sale

Orexigen's Contrave joined a couple other FDA-approved weight-loss treatments on the market ... and the OREX product is a serious player. More